Evidence map›Paper›PMID 38354778›Full record

ArticleThe Journal of biological chemistry2024

Engineering of glycoside hydrolase family 7 cellobiohydrolases directed by natural diversity screening.

Roman Brunecky, Brandon C Knott, Venkataramanan Subramanian, Jeffrey G Linger, Gregg T Beckham, Antonella Amore, Larry E Taylor, Todd A Vander Wall, Vladimir V Lunin, Fei Zheng and 6 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Roman BruneckyBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Brandon C KnottBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Venkataramanan SubramanianBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Jeffrey G LingerBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Gregg T BeckhamBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Antonella AmoreBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Larry E TaylorBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Todd A Vander WallBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Vladimir V LuninBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Fei ZhengBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Mercedes GarridoBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Logan SchusterBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Emily M FulkBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Samuel FarmerBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA.
Michael E HimmelBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA. Electronic address: mike.himmel@nrel.gov.
Stephen R DeckerBioenergy Science and Technology Directorate, National Renewable Energy Laboratory, Golden, Colorado, USA. Electronic address: steve.decker@nrel.gov.
National Laboratory of the Rockies · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein engineering and screening of processive fungal cellobiohydrolases (CBHs) remain challenging due to limited expression hosts, synergy-dependency, and recalcitrant substrates. In particular, glycoside hydrolase family 7 (GH7) CBHs are critically important for the bioeconomy and typically difficult to engineer. Here, we target the discovery of highly active natural GH7 CBHs and engineering of variants with improved activity. Using experimentally assayed activities of genome mined CBHs, we applied sequence and structural alignments to top performers to identify key point mutations linked to improved activity. From ∼1500 known GH7 sequences, an evolutionarily diverse subset of 57 GH7 CBH genes was expressed in Trichoderma reesei and screened using a multiplexed activity screening assay. Ten catalytically enhanced natural variants were identified, produced, purified, and tested for efficacy using industrially relevant conditions and substrates. Three key amino acids in CBHs with performance comparable or superior to Penicillium funiculosum Cel7A were identified and combinatorially engineered into P. funiculosum cel7a, expressed in T. reesei, and assayed on lignocellulosic biomass. The top performer generated using this combined approach of natural diversity genome mining, experimental assays, and computational modeling produced a 41% increase in conversion extent over native P. funiculosum Cel7A, a 55% increase over the current industrial standard T. reesei Cel7A, and 10% improvement over Aspergillus oryzae Cel7C, the best natural GH7 CBH previously identified in our laboratory.

Indexed as

Cellulose 1,4-beta-CellobiosidaseEnzyme AssaysGenome, FungalMutationProtein EngineeringAspergillus oryzaeBiocatalysisLigninSubstrate SpecificityTalaromycesTrichodermaCellulose 1,4-beta-CellobiosidaseLigninlignocellulosecellobiohydrolasecellulasecelluloseenzyme improvementgenomicsprotein engineeringrational design

Identifiers

PMID38354778
PMCPMC10943489
OpenAlexW4391787476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.